ARTICLE | Clinical News
Surepost repaglinide regulatory update
March 11, 2013 7:00 AM UTC
Dainippon said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an expanded label for Type II diabetes drug Surepost repaglinide tablets to include combination therapy with thiazolidinedi...